RGH-188

 

Topic mentions per year

Topic mentions per year

2008-2016
01220082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Cariprazine (RGH-188) is a novel antipsychotic drug that exerts partial agonism of dopamine D2/D3 receptors with preferential… (More)
Is this relevant?
Review
2016
Review
2016
Cariprazine (RGH-188, MP-214, Vraylar[TM]) is a new dopamine receptor ligand developed for the treatment of several… (More)
Is this relevant?
2012
2012
Medicinal chemistry optimization of an impurity isolated during the scale-up synthesis of a pyridylsulfonamide type dopamine D(3… (More)
Is this relevant?
2012
2012
Cariprazine (RGH-188) is a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate for the treatment of… (More)
  • figure 1
  • figure 2
Is this relevant?
2011
2011
We investigated the in vivo effects of orally administered cariprazine (RGH-188; trans-N-{4-[2-[4-(2,3-dichlorophenyl)-piperazin… (More)
Is this relevant?
2011
2011
Cariprazine is a novel antipsychotic drug candidate that exhibits high selectivity and affinity to dopamine D3 and D2 receptors… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2011
2011
Aripiprazole is the first dopamine D(2)/D(3) receptor partial agonist successfully developed and ultimately approved for… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a… (More)
Is this relevant?
2010
2010
Cariprazine (RGH-188), which is being codeveloped by Gedeon Richter Ltd, Forest Laboratories Inc and Mitsubishi Tanabe Pharma… (More)
Is this relevant?
2008
2008
Selective and sensitive LC-MS/MS methods have been developed and validated for simultaneous determination of RGH-188, a novel… (More)
  • figure 2
  • figure 3
  • table 2
  • table 3
  • table 4
Is this relevant?